Lowenfeld L, Mick R, Datta J, Xu S, Fitzpatrick E, Fisher C, Fox K, DeMichele A, Zhang P, Weinstein S, Roses R and Czerniecki B: Dendritic cell vaccination enhances immune responses and induces regression of HER2pos DCIS independent of route: Results of randomized selection design trial. Clinical Cancer Research 23(12): 2961-2971, June 2017.
Huang A, Postow M, Orlowski R, Mick R, Bengsch B, Manne S, Xu W, Harmon D, Adamow M, Kuk D, Panageas K, Carrera C, Wong P, Quagliarello F, Pauken K, Herati R, McGettigan S, Kothari S, George S, Wenz B, D’Andrea K, Xu X, Amaravadi R, Schuchter L, Nathanson K, Wolchok J, Gangadhar T and Wherry EJ: T-cell invigoration to tumour burden ratio associated with anti-PD-1 response. Nature 545(7652): 60-65, May 2017.
De La Cruz L, McDonald E, Mick R, Datta J, Nocera N, Xu S, Fisher C and Czerniecki B: Anti-her2 CD4+ T-Helper type 1 immune response is superior to breast MRI for assessing response to neoadjuvant therapy in patients with HER2-positive breast cancer. Annals of Surgical Oncology 24(4): 1057-1063, April 2017.
Chao H-H, Berman A, Ciunci C, Lin H, Both S, Langer C, Lelionis K, Rengan R, Hahn S, Fagundes M, Hartsell W, Gabriel P, Simone C, Mick R and Plastaras J: Multi-institutional prospective study of reirradiation with proton beam radiotherapy for locoregionally recurrent non-small cell lung cancer. Journal of Thoracic Oncology 12(2): 281-292, February 2017.
Narayan V, Vapiwala N, Mick R, Subramanian P, Christodouleas J, Bekelman J, Deville C, Rajendran R and Haas N: Phase I trial of everolimus and radiation therapy for salvage treatment of biochemical recurrence in prostate cancer patients following prostatectomy. International Journal of Radiation Oncology·Biology·Physics 97(2): 355-361, February 2017.
Moy R, Huffman A, Richman L, Crisalli L, Wang X. Hoxie J, Mick R, Emerson S, Zhang Y, Vonderheide R, Porter D and Reshef R: Clinical and immunologic impact of CCR5 blockade in graft-versus-host disease prophylaxis. Blood 129(7): 906-916, February 2017.
Lowenfeld L, Zaheer S, Oechsle C, Fracol M, Datta J, Xu S, Fitzpatrick E, Roses R, Fisher C, McDonald E, Zhang P, DeMichele A, Mick R, Koski G and Czerniecki B: Addition of anti-estrogen therapy to anti-HER2 dendritic cell vaccination improves regional nodal immune response and pathologic complete response rate in patients with ERpos/HER2pos early breast cancer. OncoImmunology July 2016 Notes: epub DOI: 10.1080/2162402X.2016.1207032.
Fernandes A, Berman A, Mick R, Both S, Lelionis K, Lukens J, Ben-Josef E, Metz J and Plastaras J: A prospective study of proton beam reirradiation for esophageal cancer. International Journal of Radiation Oncology · Biology · Physics 95(95): 483-7, May 2016.
Ahn P, Quon H, O’Malley B, Weinstein G, Chalian A, Malloy K, Atkins J, Sollecito T, Greenberg M, McNulty S, Lin A, Zhu T, Finlay J, Cengel K, Livosi V, Feldman M, Mick R and Busch T: Toxicities and early outcomes in a phase 1 trial of photodynamic therapy for premalignant and early stage head and neck tumors. Oral Oncology 55: 37-42, April 2016.
Levy J, Sudheendra D, Dagli M, Mondschein J, Stavropoulos W, Shlansky-Goldberg R, Trerotola S, Teitelbaum U, Mick R, Soulen M: Percutaneous biliary drainage effectively lowers serum bilirubin to permit chemotherapy treatment. Abdominal Radiology New York 41(2): 317-23, February 2016.
back to top
Last updated: 02/13/2018
The Trustees of the University of Pennsylvania